DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation
Atrial fibrillation (AF) is accompanied by a detrimental loss of functional cardiomyocytes. Here, Zhang et al. show that AF-induced cardiomyocyte dysfunction is a consequence of DNA damage-mediated PARP1 activation, which leads to depletion of NAD+ and further oxidative stress and DNA damage, and id...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f755550b82b4522aecca3e20910e91e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9f755550b82b4522aecca3e20910e91e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9f755550b82b4522aecca3e20910e91e2021-12-02T17:01:32ZDNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation10.1038/s41467-019-09014-22041-1723https://doaj.org/article/9f755550b82b4522aecca3e20910e91e2019-03-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-09014-2https://doaj.org/toc/2041-1723Atrial fibrillation (AF) is accompanied by a detrimental loss of functional cardiomyocytes. Here, Zhang et al. show that AF-induced cardiomyocyte dysfunction is a consequence of DNA damage-mediated PARP1 activation, which leads to depletion of NAD+ and further oxidative stress and DNA damage, and identify PARP1 inhibition as a potential therapeutic strategy in the treatment of AF.Deli ZhangXu HuJin LiJia LiuLuciënne Baks-te BulteMarit WiersmaNoor-ul-Ann MalikDenise M. S. van MarionMarziyeh ToloueeFemke Hoogstra-BerendsEva A. H. LantersArie M. van RoonAntoine A. F. de VriesDaniël A. PijnappelsNatasja M. S. de GrootRobert H. HenningBianca J. J. M. BrundelNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-17 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Deli Zhang Xu Hu Jin Li Jia Liu Luciënne Baks-te Bulte Marit Wiersma Noor-ul-Ann Malik Denise M. S. van Marion Marziyeh Tolouee Femke Hoogstra-Berends Eva A. H. Lanters Arie M. van Roon Antoine A. F. de Vries Daniël A. Pijnappels Natasja M. S. de Groot Robert H. Henning Bianca J. J. M. Brundel DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation |
description |
Atrial fibrillation (AF) is accompanied by a detrimental loss of functional cardiomyocytes. Here, Zhang et al. show that AF-induced cardiomyocyte dysfunction is a consequence of DNA damage-mediated PARP1 activation, which leads to depletion of NAD+ and further oxidative stress and DNA damage, and identify PARP1 inhibition as a potential therapeutic strategy in the treatment of AF. |
format |
article |
author |
Deli Zhang Xu Hu Jin Li Jia Liu Luciënne Baks-te Bulte Marit Wiersma Noor-ul-Ann Malik Denise M. S. van Marion Marziyeh Tolouee Femke Hoogstra-Berends Eva A. H. Lanters Arie M. van Roon Antoine A. F. de Vries Daniël A. Pijnappels Natasja M. S. de Groot Robert H. Henning Bianca J. J. M. Brundel |
author_facet |
Deli Zhang Xu Hu Jin Li Jia Liu Luciënne Baks-te Bulte Marit Wiersma Noor-ul-Ann Malik Denise M. S. van Marion Marziyeh Tolouee Femke Hoogstra-Berends Eva A. H. Lanters Arie M. van Roon Antoine A. F. de Vries Daniël A. Pijnappels Natasja M. S. de Groot Robert H. Henning Bianca J. J. M. Brundel |
author_sort |
Deli Zhang |
title |
DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation |
title_short |
DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation |
title_full |
DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation |
title_fullStr |
DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation |
title_full_unstemmed |
DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation |
title_sort |
dna damage-induced parp1 activation confers cardiomyocyte dysfunction through nad+ depletion in experimental atrial fibrillation |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/9f755550b82b4522aecca3e20910e91e |
work_keys_str_mv |
AT delizhang dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT xuhu dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT jinli dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT jialiu dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT luciennebakstebulte dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT maritwiersma dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT noorulannmalik dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT denisemsvanmarion dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT marziyehtolouee dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT femkehoogstraberends dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT evaahlanters dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT ariemvanroon dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT antoineafdevries dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT danielapijnappels dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT natasjamsdegroot dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT roberthhenning dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation AT biancajjmbrundel dnadamageinducedparp1activationconferscardiomyocytedysfunctionthroughnaddepletioninexperimentalatrialfibrillation |
_version_ |
1718382098993119232 |